[{"Assets_0_Q2_USD":341341000.0,"CommonStockSharesOutstanding_0_Q2_shares":27258000.0,"EarningsPerShareBasic_1_Q2_USD":0.05,"EarningsPerShareBasic_2_Q2_USD":0.17,"EarningsPerShareDiluted_1_Q2_USD":0.05,"EarningsPerShareDiluted_2_Q2_USD":0.17,"NetIncomeLoss_1_Q2_USD":1326000.0,"NetIncomeLoss_2_Q2_USD":4638000.0,"StockholdersEquity_0_Q2_USD":218010000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":27618000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":27572000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":27249000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":27234000.0,"Ticker":"LNDC","CIK":"1005286","name":"LANDEC CORP CA","OfficialName":"Landec Corporation Common Stock (DE)","form":"10-Q","period":"20161130","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"306028744.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170105"}]